Fibroblast Activation Protein Inhibitor Theranostics: A Huge Opportunity with its Fair Share of Oncological Pitfalls.

Autor: Al-Ibraheem, Akram1,2,3 (AUTHOR) aibraheem@khcc.jo
Zdroj: World Journal of Nuclear Medicine. Jun2024, Vol. 23 Issue 2, p71-72. 2p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje